#biologics
We are the largest oncology player in India, says Zydus MD; eyes US speciality push
Zydus’ oncology business is supported by early entry into complex biologics and targeted therapies, along with structured patient support programmes that have improved access across treatment lines
Cell Banking Outsourcing Market: 16%+ CAGR (2026-2031), Expanding with Rising Demand for Biologics and Regenerative Medicine Services, Says Mordor Intelligence
The cell banking outsourcing market is witnessing strong growth driven by increasing demand for biologics, rising adoption of cell and gene therapies, and growing investment in regenerative medicine and biopharmaceutical research. North America currently lead…
Global Alzheimer's Therapeutics Market Expands at 9.3% CAGR as Biologics and Early Diagnosis Transform Dementia Care
NEWARK, Del., May 20, 2026 /PRNewswire/ -- The global Alzheimer's Therapeutics Market is projected to grow from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, expanding at a CAGR of 9.3% during the forecast period. According to Future Market Insights (F…
Global Alzheimer's Therapeutics Market Expands at 9.3% CAGR as Biologics and Early Diagnosis Transform Dementia Care
NEWARK, Del., May 20, 2026 /PRNewswire/ -- The global Alzheimer's Therapeutics Market is projected to grow from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, expanding at a CAGR of 9.3% during the forecast period. According to Future Market Insights (F…
Contract Manufacturing Organizations (CMOs) Emerging Market Outsourcing Report 2026: China Releases New Revision of Drug Administration Law, Aiming to Spur Innovation
Emerging markets offer significant opportunities in pharmaceutical manufacturing, highlighted by trends in CMOs, M&A activities, and service agreements. Insights into biologics, chemical APIs, and dose manufacturing in clinical and commercial settings are cru…
Biologics CDMO Research Report 2026: $48.07 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
The biologics CDMO market presents growth opportunities driven by increasing demand for cell and gene therapies, advancements in bioprocessing technologies, and the expansion of global manufacturing capacities. The rise in biosimilar pipelines and need for co…